CN104288089A - Separated-type suppository combination treatment unit - Google Patents

Separated-type suppository combination treatment unit Download PDF

Info

Publication number
CN104288089A
CN104288089A CN201410421415.6A CN201410421415A CN104288089A CN 104288089 A CN104288089 A CN 104288089A CN 201410421415 A CN201410421415 A CN 201410421415A CN 104288089 A CN104288089 A CN 104288089A
Authority
CN
China
Prior art keywords
suppository
key
split type
combined therapy
therapy unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410421415.6A
Other languages
Chinese (zh)
Inventor
邱学良
邱明世
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbin OT Pharmaceutical Co Ltd
Original Assignee
Harbin OT Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbin OT Pharmaceutical Co Ltd filed Critical Harbin OT Pharmaceutical Co Ltd
Priority to CN201410421415.6A priority Critical patent/CN104288089A/en
Publication of CN104288089A publication Critical patent/CN104288089A/en
Pending legal-status Critical Current

Links

Landscapes

  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

The invention discloses a separated-type suppository combination treatment unit, which comprises a package inner box, a suppository body and an expansion carrier. The package inner box is used for filling the suppository body and the expansion carrier, the suppository body and the expansion carrier are designed in a separated mode; and a groove is arranged at end of the suppository body. The separated-type suppository combination treatment unit has the advantages of convenient usage, simple operation, safety and sanitation, can prevent suppository pollution and human infection, and facilitates processing, molding and packaging of the inner package box; and is convenient for connection and usage of the suppository body and the expansion carrier; and can effectively avoid the adsorption of effective component in the suppository body by the expansion carrier, and thereby curative effect is prevented to be influenced due to low concentration of the effective component; moisture and decomposition can be effectively prevented, the melting of the suppository body due to increased temperature can be prevented, and the reduction of suppository body drug effect is prevented.

Description

A kind of split type suppository combined therapy unit
Technical field
The invention belongs to the drug world of suppository, particularly one split type suppository combined therapy unit.
Technical background
General conventional suppository is DNAcarrier free, and the substrate of medicine and its filling effect is mixed and made into effigurate cylinder suppository, relies on suppository base constantly dissolve and slowly release medicine in vivo, reaches the effect of medical treatment.But the suppository dissolved can not in time completely by body absorption, and in use due to medicine and substrate outflow, meeting pollution clothes, makes troubles to user.And the concentration that this outflow also can cause medicine can not remain valid for a long time in vivo.Therefore the many structure of technical staff to suppository are improved, and make tampon integrated with suppository, medicinal liquid can be avoided to flow out, do not pollute clothing.And can drug absorption be promoted, long action time, use the advantages such as easy to carry.But tampon and suppository integrated design, can produce following problem: 1. tampon easily absorbs the effective ingredient in suppository, reduce the curative effect of suppository; 2. tampon easily pollutes and absorbs antibacterial, during integrated design, receives pollution, and then cause human infection between suppository meeting; 3. tampon and suppository integrated design, is unfavorable for machine-shaping and the packaging of inner packaging box.
Summary of the invention
The object of this invention is to provide a kind of easy to use, simple to operate, safety and sanitation, prevent suppository from polluting and human infection, the machine-shaping being easy to inner packaging box and packaging split type suppository combined therapy unit.
Split type suppository combined therapy unit of the present invention, comprises packaging inner box, key and expandable carrier; Packaging inner box is used for splendid attire key and expandable carrier; Key and expandable carrier split-type design; Key end belt is fluted.
Split type suppository combined therapy unit of the present invention, easy to use, simple to operate, adopt split-type design can effectively ensure suppository safety and sanitation, prevent suppository from polluting and patient cross infection occurs when using, be easy to machine-shaping and the packaging of inner packaging box.
Further, groove is cylindrical slot; Expandable carrier 3 end be provided with groove 21 with the use of plush copper 31.
This design facilitates the use of expandable carrier.
Further, groove inner surface is provided with intra-striate; Plush copper is provided with intra-striate with the use of outer striped.
This design facilitates the connection of expandable carrier and key.
Split type suppository combined therapy unit of the present invention, expandable carrier is cotton sliver.
Preferably, split type suppository combined therapy unit of the present invention, groove inner surface is coated with layer protective layer.
Protective layer can prevent expandable carrier to the absorption of effective ingredient in key, and then prevents effective ingredient concentration too low and affect the treatment.
Further preferably, protective layer is made up of one or more in polyvidone, ethyl cellulose, glycerol, gelatin or elsinan.
Further preferred, protective layer is that the polyvidone of 1:2 and elsinan form by ratio of weight and number.
Ratio of weight and number is the polyvidone of 1:2 and the protective layer of elsinan composition, expandable carrier more effectively can be prevented the absorption of effective ingredient in key, ensure the concentration of effective ingredient, and then ensure medicinal effects.
Split type suppository combined therapy unit of the present invention, packaging inner box is made up of one or more in PVC, PET, PE or PP.
PVC, polrvinyl chloride is the thermoplastic resin be polymerized under initiator effect by vinyl chloride;
PET, polyethylene terephthalate, chemical formula is-OCH2-CH2OCOC6H4CO-English name: polyethylene terephthalate, is high polymer, by ethylene glycol terephthalate generation dehydration condensation;
PE is that ethylene is through being polymerized obtained a kind of thermoplastic resin;
PP, polypropylene, English name: Polypropylene, molecular formula: (C3H6) n is a kind of thermoplastic resin obtained by propylene polymerization.
Further preferably, PVC and PET that packaging inner box is 2:3 by ratio of weight and number forms.
Ratio of weight and number be 2:3 PVC and PET composition packaging inner box, can effectively protection against the tide, anti-decomposition, can also prevent temperature from raising the key caused and dissolve, prevent key drug effect from reducing.
Split type suppository combined therapy unit of the present invention, packaging inner box 1 is by two identical package panel 11 pressing and formings; Package panel 11 is provided with several first outer tongue 12 corresponding with key 2 shape, with the second outer tongue 13 corresponding with expandable carrier 3 shape of equal number.
Key 2 is separately positioned on from expandable carrier 3 and packs in the different grooves of inner box 1, contribute to the absorption preventing effective ingredient in expandable carrier 3 pairs of keys 2, ensure the drug effect of key 2, contribute to the safety and sanitation ensureing key 2 and expandable carrier 3 simultaneously.
Beneficial effect of the present invention is:
Split type suppository combined therapy unit of the present invention, designs key and expandable carrier split, easy to use, simple to operate, safety and sanitation, prevents suppository from polluting and human infection, the machine-shaping being easy to inner packaging box and packaging; And relevant improvement has been done to the groove of key and the plush copper of expandable carrier, facilitate connection and the use of key and expandable carrier; The inner surface of key groove is arranged layer protective layer, prevents expandable carrier to the absorption of effective ingredient in key, and then prevent effective ingredient concentration too low and affect the treatment; Carry out preferably, effectively preventing expandable carrier to the absorption of effective ingredient in key to the composition of protective layer further again, ensure the concentration of effective ingredient, and then ensure medicinal effects; To packaging inner box composition improve, can effectively protection against the tide, anti-decomposition, can also prevent temperature from raising the key caused and dissolve, prevent key drug effect from reducing; Key and expandable carrier are separately positioned on and pack in the different grooves of inner box, contribute to the absorption preventing expandable carrier to effective ingredient in key, ensure the drug effect of key, contribute to the safety and sanitation ensureing key and expandable carrier simultaneously.
Accompanying drawing explanation
Fig. 1 is the structural representation of key 2 in split type suppository combined therapy unit in embodiment 1;
Fig. 2 is the structural representation of expandable carrier 3 in embodiment 1;
Fig. 3 is structural representation when key 2 coordinates with expandable carrier 3 in embodiment 1;
Fig. 4 is the structural representation of key 2 in split type suppository combined therapy unit in embodiment 2;
Fig. 5 is the structural representation of expandable carrier 3 in embodiment 2;
Fig. 6 is structural representation when key 2 coordinates with expandable carrier 3 in embodiment 2;
Fig. 7 is the structural representation of key 2 in split type suppository combined therapy unit in embodiment 3;
Fig. 8 is the structural representation of expandable carrier 3 in embodiment 3;
Fig. 9 is structural representation when key 2 coordinates with expandable carrier 3 in embodiment 3;
Figure 10 is the structural representation of key 2 in split type suppository combined therapy unit in embodiment 4;
Figure 11 is the structural representation of expandable carrier 3 in embodiment 4;
Figure 12 is structural representation when key 2 coordinates with expandable carrier 3 in embodiment 4;
Figure 13 is the plan structure schematic diagram of key 2 in embodiment 1,2;
Figure 14 is the plan structure schematic diagram of key 2 in embodiment 3,4,5;
Figure 15 is the structural representation of embodiment 1-5 intermediate package sheet 11;
Figure 16 is the A-A view of Figure 15 intermediate package sheet 11;
Figure 17 is the B-B view of Figure 15 intermediate package sheet 11;
Figure 18 is the structural representation of embodiment 1-5 intermediate package inner box 1;
Figure 19 is the C-C view of Figure 18 intermediate package inner box 1;
Figure 20 is the D-D view of Figure 18 intermediate package inner box 1;
Figure 21 is the C-C view of Figure 20 intermediate package inner box 1;
Figure 22 is the D-D view of Figure 20 intermediate package inner box 1.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1
As Fig. 1-3,13, shown in 17-22,1 is packaging inner box, and 11 is package panel, and 12 is the first outer tongue, and 13 is the second outer tongue; 2 is key, and 21 is groove; 3 is expandable carrier, and 31 is plush copper.
As Fig. 1-3,13, shown in 17-22, split type suppository combined therapy unit of the present invention, packaging inner box 1, key 2 and expandable carrier 3; Packaging inner box 1 is for splendid attire key 2 and expandable carrier 3; Key 2 and expandable carrier 3 split-type design; Key 2 end belt fluted 21; Groove 21 is cylindrical slot, expandable carrier 3 end be provided with groove 21 with the use of plush copper 31; During use, key 2 and expandable carrier 3 by groove 21 and plush copper 31 with the use of; Packaging inner box 1 is by two identical package panel 11 pressing and formings; Package panel 11 is provided with several first outer tongue 12 corresponding with key 2 shape, with the second outer tongue 13 corresponding with expandable carrier 3 shape of equal number; Key 2 and expandable carrier 3 are placed in respectively in the first outer tongue 12 in package panel 11 and the second outer tongue 13, then pressing two panels package panel 11, forms complete split type suppository combined therapy unit.
The split type suppository combined therapy unit of the present embodiment, designs key and expandable carrier split, easy to use, simple to operate, safety and sanitation, prevents suppository from polluting and human infection, the machine-shaping being easy to inner packaging box and packaging.
Embodiment 2
As Fig. 4-6,14, shown in 17-22,1 is packaging inner box, and 11 is package panel, and 12 is the first outer tongue, and 13 is the second outer tongue; 2 is key, and 21 is groove; 3 is expandable carrier, and 31 is plush copper.
As Fig. 4-6,14, shown in 17-22, split type suppository combined therapy unit of the present invention, groove 21 inner surface is provided with intra-striate; Plush copper 31 is provided with described intra-striate with the use of outer striped; Packaging inner box 1 is made up of PE; All the other are all identical with embodiment 1.
Because groove 21 inner surface is provided with intra-striate, plush copper 31 is provided with described intra-striate with the use of outer striped, relative to embodiment 1, the split type suppository combined therapy unit of the present embodiment, the connection of key and expandable carrier and use more convenient.
Embodiment 3
As Fig. 7-9,15, shown in 17-22,1 is packaging inner box, and 11 is package panel, and 12 is the first outer tongue, and 13 is the second outer tongue; 2 is key, and 21 is groove, and 22 is protective layer; 3 is expandable carrier, and 31 is plush copper.
As Fig. 7-9,15, shown in 17-22, split type suppository combined therapy unit of the present invention, groove 21 inner surface is coated with layer protective layer 22; Packaging inner box 1 is made up of PP; All the other are all identical with embodiment 1.
Because groove 21 inner surface is coated with layer protective layer 22, existing for embodiment 1, the split type suppository combined therapy unit of the present embodiment, can prevent expandable carrier to the absorption of effective ingredient in key, and then prevent effective ingredient concentration too low and affect the treatment.
Embodiment 4
As shown in Figure 10-12,16-22,1 is packaging inner box, and 11 is package panel, and 12 is the first outer tongue, and 13 is the second outer tongue; 2 is key, and 21 is groove, and 22 is protective layer; 3 is expandable carrier, and 31 is plush copper.
As shown in Figure 10-12,16-22, split type suppository combined therapy unit of the present invention, groove 21 inner surface is coated with layer protective layer 22; Protective layer 22 is made up of gelatin, PVC and PET that packaging inner box 1 is 2:3 by ratio of weight and number forms; All the other are all identical with embodiment 2.
PVC and PET being 2:3 by ratio of weight and number due to packaging inner box 1 forms, relative to embodiment 2, the split type suppository combined therapy unit of the present embodiment, can effectively protection against the tide, anti-decomposition, can also prevent from temperature from raising the key caused to dissolve, prevent key drug effect from reducing.
Embodiment 5
As shown in Figure 10-12,14-20,1 is packaging inner box, and 11 is package panel, and 12 is the first outer tongue, and 13 is the second outer tongue; 2 is key, and 21 is groove, and 22 is protective layer; 3 is expandable carrier, and 31 is plush copper.
As shown in Figure 10-12,14-20, split type suppository combined therapy unit of the present invention, protective layer 22 is that the polyvidone of 1:2 and elsinan form by ratio of weight and number; All the other are all identical with embodiment 4.
Because protective layer 22 is that the polyvidone of 1:2 and elsinan form by ratio of weight and number; relative to embodiment 4; the split type suppository combined therapy unit of the present embodiment; carry out preferably to the composition of protective layer further; effectively prevent the absorption of expandable carrier to effective ingredient in key; ensure the concentration of effective ingredient, and then ensure medicinal effects.
Split type suppository combined therapy unit of the present invention, designs key and expandable carrier split, easy to use, simple to operate, safety and sanitation, prevents suppository from polluting and human infection, the machine-shaping being easy to inner packaging box and packaging; And relevant improvement has been done to the groove of key and the plush copper of expandable carrier, facilitate connection and the use of key and expandable carrier; The inner surface of key groove is arranged layer protective layer, prevents expandable carrier to the absorption of effective ingredient in key, and then prevent effective ingredient concentration too low and affect the treatment; Carry out preferably, effectively preventing expandable carrier to the absorption of effective ingredient in key to the composition of protective layer further again, ensure the concentration of effective ingredient, and then ensure medicinal effects; To packaging inner box composition improve, can effectively protection against the tide, anti-decomposition, can also prevent temperature from raising the key caused and dissolve, prevent key drug effect from reducing; Key and expandable carrier are separately positioned on and pack in the different grooves of inner box, contribute to the absorption preventing expandable carrier to effective ingredient in key, ensure the drug effect of key, contribute to the safety and sanitation ensureing key and expandable carrier simultaneously.

Claims (10)

1. a split type suppository combined therapy unit, is characterized in that, described treatment unit comprises packaging inner box (1), key (2) and expandable carrier (3); Described packaging inner box (1) is for key described in splendid attire (2) and expandable carrier (3); Described key (2) and expandable carrier (3) split-type design; Described key (2) end belt fluted (21).
2. split type suppository combined therapy unit according to claim 1, it is characterized in that, described groove (21) is cylindrical slot; Described expandable carrier (3) end be provided with described groove (21) with the use of plush copper (31).
3. split type suppository combined therapy unit according to claim 2, it is characterized in that, described groove (21) inner surface is provided with intra-striate; Described plush copper (31) is provided with described intra-striate with the use of outer striped.
4. split type suppository combined therapy unit according to claim 1, it is characterized in that, described expandable carrier (3) is cotton sliver.
5. the split type suppository combined therapy unit according to any one of Claims 1 to 4, it is characterized in that, described groove (21) inner surface is coated with layer protective layer (22).
6. split type suppository combined therapy unit according to claim 5, it is characterized in that, described protective layer (22) is made up of one or more in polyvidone, ethyl cellulose, glycerol, gelatin or elsinan.
7. split type suppository combined therapy unit according to claim 6, is characterized in that, described protective layer is that the polyvidone of 1:2 and elsinan form by ratio of weight and number.
8. the split type suppository combined therapy unit according to any one of Claims 1 to 4, is characterized in that, described packaging inner box (1) is made up of one or more in PVC, PET, PE or PP.
9. split type suppository combined therapy unit according to claim 8, is characterized in that, PVC and PET that described packaging inner box (1) is 2:3 by ratio of weight and number forms.
10. the split type suppository combined therapy unit according to any one of Claims 1 to 4, is characterized in that, described packaging inner box (1) is by two identical package panel (11) pressing and formings; Described package panel (11) is provided with the first outer tongue (12) that several and described key (2) shape is corresponding, with the second outer tongue (13) corresponding with described expandable carrier (3) shape of equal number.
CN201410421415.6A 2014-08-25 2014-08-25 Separated-type suppository combination treatment unit Pending CN104288089A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410421415.6A CN104288089A (en) 2014-08-25 2014-08-25 Separated-type suppository combination treatment unit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410421415.6A CN104288089A (en) 2014-08-25 2014-08-25 Separated-type suppository combination treatment unit

Publications (1)

Publication Number Publication Date
CN104288089A true CN104288089A (en) 2015-01-21

Family

ID=52308208

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410421415.6A Pending CN104288089A (en) 2014-08-25 2014-08-25 Separated-type suppository combination treatment unit

Country Status (1)

Country Link
CN (1) CN104288089A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1795838A (en) * 2004-12-28 2006-07-05 哈尔滨欧替药业股份有限公司 Cotton bar, cotton bar type suppository and preparing technique
CN103181889A (en) * 2012-11-29 2013-07-03 哈尔滨欧替药业有限公司 Expandable vaginal suppository

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1795838A (en) * 2004-12-28 2006-07-05 哈尔滨欧替药业股份有限公司 Cotton bar, cotton bar type suppository and preparing technique
CN103181889A (en) * 2012-11-29 2013-07-03 哈尔滨欧替药业有限公司 Expandable vaginal suppository

Similar Documents

Publication Publication Date Title
DK2802319T3 (en) FIXED DOSAGE COMBINATION THERAPY FOR PARKINSON'S DISEASE
CN104288089A (en) Separated-type suppository combination treatment unit
CN202537783U (en) Environment-friendly radix polygonati officinalis fiber diaper pants
CN204815109U (en) Protection arm cover
CN201356870Y (en) Self-destroying type quantitative injector
CN204032385U (en) A kind of socks
CN204618584U (en) A kind of can the sanitary pad of powder charge thing
CN202456428U (en) Body-building socks for children
CN202682391U (en) Poultice patch for treating pain at necks, shoulders, waists and legs
CN202105203U (en) Sticking membrane for dermatosis and ulcer wound surface
CN104069568B (en) A kind of safety device that can lock injection needle
CN208552545U (en) A kind of follow-on anti-abuse opiates nerve anesthesia analgesic patch framework
CN204798404U (en) Novel chitosan gel tie
CN205083909U (en) Treatment vehicle
CN204910160U (en) Chinese yew compound health care cream
CN207785576U (en) A kind of immunization box
CN106666838A (en) Hemostatic sock
CN204484483U (en) A kind of adhesive bandages
CN207412303U (en) A kind of disposable drug nursing plaster for site of injury
CN205698756U (en) A kind of entry needle safety guard
CN202397961U (en) Vagina medicating device
CN106860590A (en) A kind of medicinal liquor suitable for hernia
CN204106573U (en) One is simple and easy prevents eating capsule bottle by mistake
CN204951334U (en) A functional wound dressing of novel biology for wound disinfects
CN204951733U (en) A gauze for wound orthopaedics patient

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150121